Lu Daopei, M.D.
Professor Lu Daopei, M.D served as director of Peking University Institute of Hematology from 1981-2005. Dr. Lu was elected as a permanent member (academician) of Chinese Academy of Engineering, was elected as a member of the second presidium of CAE. He is a member of Academic Committee of Peking University Health Science Center; Chair of Hematology at Peking University Health Science Center; a member of the Standing Committee of Chinese Medical Association; Chairman of the Committee of Medical Nomenclature; President of the Chinese Society of Hematology CMA; and Chairman of the Committee of Hematologic Malignancies of the CACA. In 2002, Dr. Lu was elected to be the vice president of Asian Hematology Association, and he was the Chairman of the 11th Congress of International Society of Hematology-Asian Pacific Division. Dr. Lu is a prolific writer and medical researcher with publication of more than 300 peer-reviewed articles, reviews and book chapters.
Frank McCormick, Ph.D
Frank McCormick, Ph.D., F.R.S., is the Director of the University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, and is the David A. Wood Distinguished Professor of Tumor Biology and Cancer Research and the E. Dixon Heise Distinguished Professorship in Oncology, and Associate Dean of the UCSF School of Medicine. Before assuming his current affiliation with UCSF, Dr. McCormick was the founder and chief scientific officer at Onyx Pharmaceuticals. He also previously served as vice president of research at Chiron Corporation, and vice president of research at Cetus Corporation. Dr. McCormick received his Bachelor of Science degree in biochemistry from the University of Birmingham, England and his Ph.D in biochemistry from the University of Cambridge, England. Dr. McCormick has received numerous awards in recognition of his contributions to the field of cancer research, authored more than 200 scientific publications and edited five books, and holds 21 patents.
W. Michael Korn, M.D.
W. Michael Korn, M.D. is an Associate Professor in Medicine at the University of California at San Francisco specializing in Gastroenterology and Medical Oncology. He is Co-Director of the Center of Molecular Oncology at the USCF Helen Diller Family Comprehensive Cancer Center, where technologies for molecular tumor characterization are being used in the development of personalized cancer treatment protocols. Dr. Korn is also a physician-scientist trained in medical oncology and gastroenterology. Dr. Korn founded Targeted Therapeutics Consulting, Inc., an information technology company focused on the development of web-accessible databases (including CuraBase.com) for biomedical applications. Dr. Korn is the principal investigator on various NIH-funded research projects, focusing on target identification in pathways down-stream of Ras using system-biology and mathematical modeling approaches. Dr. Korn’s work has been published in prestigious scientific publications, including Nature Medicine.
Evan Y. Snyder, M.D., Ph.D.
Evan Y. Snyder earned his M.D. and Ph.D. (in neuroscience) from the University of Pennsylvania in 1980 as a member of NIH’s Medical Scientist Training Program (MSTP). (He had also studied psychology and linguistics at the University of Oxford). After moving to Boston in 1980, he completed residencies in pediatrics and neurology as well as a clinical fellowship in Neonatal-Perinatal Medicine at Children’s Hospital-Boston, Harvard Medical School. He also served as Chief Resident in Medicine (1984-85) and Chief Resident in Neurology (1987) at Children’s Hospital-Boston. In 1989, he became an attending physician in the Department of Pediatrics (Division of Newborn Medicine) and Department of Neurology at Children’s Hospital-Boston, Harvard Medical School. From 1985-91, concurrent with his clinical activities, he conducted postdoctoral research as a fellow in the Department of Genetics, Harvard Medical School. In 1992, Dr. Snyder was appointed an instructor in neurology (neonatology) at Harvard Medical School and was promoted to assistant professor in 1996. He maintained lab spaces in both Children’s Hospital-Boston and at Harvard Institutes of Medicine/Beth-Israel Deaconess Medical Center. In 2003, Dr. Snyder was recruited to the Burnham Institute for Medical Research as Professor and Director of the Program in Stem Cell & Regenerative Biology. He then inaugurated the Stem Cell Research Center (serving as its founding director) and initiated the Southern California Stem Cell Consortium. Dr. Snyder is a Fellow of the American Academy of Pediatrics (FAAP). He also received training in Philosophy and Linguistics at Oxford University.
For more information visit: http://www.sanfordburnham.org/research_and_faculty/faculty_search/snyder_e_md_phd.aspx